Aripiprazole, a partial dopaminergic agonist, represents a well-tolerated and effective addition to the antipsychotic armamentarium. However, accumulated data indicates that aripiprazole may still induce extrapyramidal side effects (EPS) in susceptible patients. Guidelines for treating schizophrenia have consistently recommended antipsychotic monotherapy. Nevertheless, in certain clinical situations, a thorough evaluation of the benefit/risk ratio suggests that combinations of antipsychotic agents may improve treatment efficacy and tolerability. We report a schizophrenic patient for whom sequential administration of aripiprazole and risperidone induced severe EPS, and subsequent combination therapy with of clozapine and aripiprazole achieved adequate symptom control and markedly reduced EPS.
American Psychiatric Association (2004) Practice guidelines for the treatment of patients with schizophrenia . Am J Psychiatry161: 1-56
2.
Centorrino F., Goren J.L., Hennen J., Salvatore P., Kelleher J.P., Baldessarini R.J. (2004) Multiple versus single antipsychotic agents for hospitalized psychiatric patients: Case-control study of risks versus benefits . Am J Psychiatry161: 700-706
3.
Chengappa K.N., Vasile J., Levine J., Ulrich R., Baker R., Gopalani A. et al. (2002) Clozapine: its impact on aggressive behavior among patients in a state psychiatric hospital. Schizophr Res53(1-2): 1-6
4.
Clarke L.A., Lindenmayer J.P., Kaushik S. (2006) Clozapine augmentation with aripiprazole for negative symptoms. J Clin Psychiatry67(4): 275-276
5.
Cohen S.T., Rulf D., Pies R. ( 2005) Extrapyramidal side effects associated with aripiprazole coprescription in two patients. J Clin Psychiatry66: 135-136
6.
Desarkar P., Thakur A., Sinha V. K (2006) Aripiprazole-induced acute dystonia. Am J Psychiatry163: 1112-1113
7.
Faries D., Ascher-Svanum H., Zhu B., Correll C., Kane J. ( 2005) Antipsychotic monotherapy and polypharmacy in the naturalistic treatment of schizophrenia with atypical antipsychotics. BMC Psychiatry5: 26
8.
Kapur S., Seeman P. (2001) Does fast dissociation from the dopamine D2 receptor explain the action of atypical antipsychotics? A new hypothesis. Am J Psychiatry158: 360-369
9.
Karunakaran K., Tungaraza T.E., Harborne G.C. (2007) Is clozapine-aripiprazole combination a useful regime in the management of treatment-resistant schizophrenia?J Psychopharmacol21(4): 453-456
10.
Krakowski M.I., Czobor P., Citrome L., Bark N., Cooper T.B. (2006) Atypical antipsychotic agents in the treatment of violent patients with schizophrenia and schizoaffective disorder. Arch Gen Psychiatry63(6): 622-629
Lim S., Pralea C., Schnitt J., Bowers M.B. Jr, Cooper C. (2004) Possible increased efficacy of low-dose clozapine when combined with aripiprazole. J Clin Psychiatry65(9): 1284-1285
13.
Miczek K.A., Weerts E., Haley M., Tidey J. (1994) Neurobiological mechanisms controlling aggression: preclinical developments for pharmacotherapeutic interventions. Neurosci Biobehav Rev18: 97-110
14.
Mouaffak F., Tranulis C., Gourevitch R., Poirier M.F., Douki S., Olie J.P. et al. (2006) Augmentation strategies of clozapine with antipsychotics in the treatment of ultraresistant schizophrenia. Clin Neuropharmacol29(1): 28-33
15.
Rocha F.L., Hara C. ( 2006) Benefits of combining aripiprazole to clozapine: three case reports. Prog Neuropsychopharmacol Biol Psychiatry30: 1167-1169
16.
Sharma A., Sorrell J.H. (2006) Aripiprazole-induced parkinsonism. Int Clin Psychopharmacol21: 127-129
17.
Simpson G., Angus J. (1970) A rating scale for extrapyramidal side effects . Acta Psychiatr Scand212: 11-19
18.
Stahl S. (2005) Essential psychopharmacology: neuroscientific basis and practical application, 2nd edn. Cambridge University Press, New York
19.
Tapp A., Kennedy A., Kilzieh N., Rosengren K., Wood A. ( 2004) Combination antipsychotic therapy for the treatment of schizophrenia. Essent Psychopharmacol6(1): 1-11
20.
Taylor D., Paton C., Kerwin R. (2005) The Maudsley prescribing guidelines 2005-2006, 8th edn. Taylor & Francis, London & New York
